Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Kemper (KMPB) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Kemper (KMPB) over the last 10 years, with Q4 2025 value amounting to $6.2 billion.

  • Kemper's Other Accumulated Expenses rose 665.39% to $6.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.2 billion, marking a year-over-year increase of 665.39%. This contributed to the annual value of $6.2 billion for FY2025, which is 665.39% up from last year.
  • Latest data reveals that Kemper reported Other Accumulated Expenses of $6.2 billion as of Q4 2025, which was up 665.39% from $6.1 billion recorded in Q3 2025.
  • Kemper's Other Accumulated Expenses' 5-year high stood at $6.3 billion during Q2 2022, with a 5-year trough of $2.6 billion in Q2 2024.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $5.9 billion (2021), whereas its average is $5.2 billion.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first crashed by 5756.69% in 2024, then skyrocketed by 13671.58% in 2025.
  • Kemper's Other Accumulated Expenses (Quarter) stood at $6.3 billion in 2021, then crashed by 56.33% to $2.8 billion in 2022, then decreased by 2.77% to $2.7 billion in 2023, then soared by 116.81% to $5.8 billion in 2024, then rose by 6.65% to $6.2 billion in 2025.
  • Its Other Accumulated Expenses stands at $6.2 billion for Q4 2025, versus $6.1 billion for Q3 2025 and $5.9 billion for Q2 2025.